BVS
insider transactionsBioventus Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-242.0K
0 buy · 242.0K sell
Net value · 90d
-$2.6M
$0 in · $2.6M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
1
0 buy · 242.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
25.1K sh
Own New
-
Grant·A
Director
$0
25.1K sh
Own New
-
Grant·A
Director
$0
25.1K sh
Own New
-
Grant·A
Director
$0
25.1K sh
Own New
-
Grant·A
Director
$0
25.1K sh
Own New
-
Grant·A
Director
$0
25.1K sh
Own New
-
Grant·A
Director
$0
31.0K sh
Own New
-
Grant·A
Director, 10% Owner
$0
25.1K sh
Own New
-
Grant·A
Director
$0
25.1K sh
Own New
-
Grant·A
Director, 10% Owner
$0
25.1K sh
Own New
-
Exercise·M
Director
$0
32.3K sh
Own New
-
Exercise·M
Director
$0
32.3K sh
Own +72%
-
Exercise·M
Director
$0
32.3K sh
Own New
-
Exercise·M
Director
$0
32.3K sh
Own +41%
-
Exercise·M
Director
$0
32.3K sh
Own New
-
Exercise·M
Director
$0
32.3K sh
Own +276%
-
Exercise·M
Director
$0
32.3K sh
Own New
-
Exercise·M
Director
$0
32.3K sh
Own +38%
-
Exercise·M
Director
$0
32.3K sh
Own New
-
Exercise·M
Director
$0
32.3K sh
Own +30%
-
Exercise·M
Director
$0
32.3K sh
Own New
-
Exercise·M
Director
$0
32.3K sh
Own +28%
-
Exercise·M
Director
$0
39.8K sh
Own New
-
Exercise·M
Director
$0
39.8K sh
Own +15%
-
Exercise·M
Director, 10% Owner
$0
32.3K sh
Own New
-
Exercise·M
Director, 10% Owner
$0
32.3K sh
Own +38%
-
Exercise·M
Director
$0
32.3K sh
Own New
-
Exercise·M
Director
$0
32.3K sh
Own +42%
-
Exercise·M
Director, 10% Owner
$0
32.3K sh
Own New
-
Exercise·M
Director, 10% Owner
$0
32.3K sh
Own +41%
-
Sell·S
$2.6M
242.0K sh · $10.70
Own -7%
-
Grant·A
Director
$155.0K
3.5K sh · $44.10
Own +2%
-
Exercise·M
SVP & CFO
$0
13.0K sh
Own New
-
Other·F
SVP & CFO
$51.2K
5.6K sh · $9.06
Own -3%
-
Exercise·M
SVP & CFO
$0
13.0K sh
Own +8%
-
Exercise·M
SVP & General Counsel
$0
9.9K sh
Own New
-
Other·F
SVP & General Counsel
$39.1K
4.3K sh · $9.06
Own -3%
-
Exercise·M
SVP & General Counsel
$0
9.9K sh
Own +7%
-
Exercise·M
SVP & Chief Compliance Officer
$0
4.3K sh
Own New
-
Other·F
SVP & Chief Compliance Officer
$16.9K
1.9K sh · $9.06
Own -3%
-
Exercise·M
SVP & Chief Compliance Officer
$0
4.3K sh
Own +7%
-
Grant·A
Pat Beyer KEY
President & CEO
$0
28.1K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | Michelle Mcmurry-Heath | Grant A | 25.1K | $0 |
| Jun 3, 2026 | Mary Kay Ladone | Grant A | 25.1K | $0 |
| Jun 3, 2026 | Philip G. Cowdy | Grant A | 25.1K | $0 |
| Jun 3, 2026 | Guido J Neels | Grant A | 25.1K | $0 |
| Jun 3, 2026 | Susan M Stalnecker | Grant A | 25.1K | $0 |
| Jun 3, 2026 | Guy P Nohra | Grant A | 25.1K | $0 |
| Jun 3, 2026 | William A Hawkins | Grant A | 31.0K | $0 |
| Jun 3, 2026 | Martin P Sutter | Grant A | 25.1K | $0 |
| Jun 3, 2026 | Pat Beyer | Grant A | 25.1K | $0 |
| Jun 3, 2026 | John A. Bartholdson | Grant A | 25.1K | $0 |
| Jun 2, 2026 | Michelle Mcmurry-Heath | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | Michelle Mcmurry-Heath | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | Mary Kay Ladone | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | Mary Kay Ladone | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | Philip G. Cowdy | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | Philip G. Cowdy | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | Guido J Neels | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | Guido J Neels | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | Susan M Stalnecker | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | Susan M Stalnecker | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | Guy P Nohra | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | Guy P Nohra | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | William A Hawkins | Exercise M | 39.8K | $0 |
| Jun 2, 2026 | William A Hawkins | Exercise M | 39.8K | $0 |
| Jun 2, 2026 | Martin P Sutter | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | Martin P Sutter | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | Pat Beyer | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | Pat Beyer | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | John A. Bartholdson | Exercise M | 32.3K | $0 |
| Jun 2, 2026 | John A. Bartholdson | Exercise M | 32.3K | $0 |
| May 22, 2026 | Juniper Investment Company, LLC / John A. Bartholdson / MICHAS ALEXIS P | Sell S | 242.0K | $2.6M |
| May 7, 2026 | John A. Bartholdson | Grant A | 3.5K | $155.0K |
| Apr 10, 2026 | Mark Leonard Singleton KEY | Exercise M | 13.0K | $0 |
| Apr 10, 2026 | Mark Leonard Singleton KEY | Other F | 5.6K | $51.2K |
| Apr 10, 2026 | Mark Leonard Singleton KEY | Exercise M | 13.0K | $0 |
| Apr 10, 2026 | Anthony D'Adamio | Exercise M | 9.9K | $0 |
| Apr 10, 2026 | Anthony D'Adamio | Other F | 4.3K | $39.1K |
| Apr 10, 2026 | Anthony D'Adamio | Exercise M | 9.9K | $0 |
| Apr 10, 2026 | Katrina J Church | Exercise M | 4.3K | $0 |
| Apr 10, 2026 | Katrina J Church | Other F | 1.9K | $16.9K |
| Apr 10, 2026 | Katrina J Church | Exercise M | 4.3K | $0 |
| Apr 1, 2026 | Pat Beyer KEY | Grant A | 28.1K | $0 |
About BVS insider trading
This page tracks insider transactions for Bioventus Inc. (BVS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.